Meeting Description

During this 2-hour briefing, Dr. Zerhouni and other key NIH leaders will provide specific updates on the NIH Roadmap, discuss requests for applications and other initiatives currently in circulation, describe future opportunities, and answer questions.

Representatives from academic health centers, professional organizations, and health advocacy groups are particularly encouraged to attend or participate via webcast.

Webcast viewers are invited to submit questions in advance to nihroadmap@nih.gov by February 24. The speakers will attempt to address as many questions as possible during their presentations.

If you are unable to attend the meeting, materials, speaker presentations, and a synopsis will be available on this Web site following the briefing.

Background

In September 2003, National Institutes of Health (NIH) Director Elias A. Zerhouni, M.D., laid out a series of far-reaching initiatives known collectively as the NIH Roadmap for Medical Research.

The NIH Roadmap is designed to transform the nation's medical research capabilities and speed the movement of research discoveries from the bench to the bedside.

Developed with input from more than 300 nationally recognized leaders in academia, industry, government, and the public, the NIH Roadmap provides a framework of the priorities the NIH must address to optimize its entire research portfolio. The NIH Roadmap lays out a vision for a more efficient and productive system of medical research and identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise.